Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZKAB001 maintenance in high-grade osteosarcoma
NCT04359550Phase 3Unknown
- Sponsor
- Lee's Pharmaceutical Holdings Limited
- Start
- Jun 2020
- Primary completion
- Jun 2022
- Modality
- Immune Checkpoint Inhibitors
01
Overview
A Phase 3 trial of socazolimab in osteosarcoma (OS), sponsored by Lee's Pharmaceutical Holdings Limited. Status: unknown.
02
Drugs
socazolimab
03
Conditions
osteosarcoma (OS)
Beyond the preview
Go deeper on NCT04359550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04359550.